Arthritis, Rheumatoid: Clinical Trials

3,590 trials for Arthritis, Rheumatoid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2192 completed, 489 unknown, 282 terminated, 278 recruiting. 668 Not applicable, 647 Phase 2, 479 Phase 3, 427 Phase 1, 340 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable668Completed 368, Unknown 122, Recruiting 57, Terminated 36, Not yet recruiting 35, Active not recruiting 31, Withdrawn 10, Enrolling by invitation 7, Suspended 2
Phase 2647Completed 416, Terminated 88, Unknown 47, Recruiting 46, Not yet recruiting 20, Withdrawn 18, Active not recruiting 8, Enrolling by invitation 3, Suspended 1
Phase 3479Completed 374, Unknown 39, Terminated 32, Active not recruiting 13, Recruiting 13, Withdrawn 4, Not yet recruiting 3, Enrolling by invitation 1
Phase 1427Completed 269, Recruiting 56, Terminated 31, Unknown 30, Withdrawn 15, Not yet recruiting 14, Active not recruiting 9, Enrolling by invitation 2, Suspended 1
Phase 4340Completed 199, Unknown 61, Terminated 38, Recruiting 22, Not yet recruiting 9, Withdrawn 8, Active not recruiting 3
Early Phase 129Recruiting 8, Not yet recruiting 6, Unknown 6, Completed 5, Suspended 2, Terminated 1, Withdrawn 1

Follow Arthritis, Rheumatoid: new trials by email Literature Review of Arthritis, Rheumatoid trials Research Report on Arthritis, Rheumatoid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cannabichromene Safety in Rheumatoid Arthritis
Cannabichromene - Arthritis, Rheumatoid
Phase 1 / Phase 2WithdrawnCrystal Lederhos Smith2028-07-152026-09-23
An Open-label Study of GC012F in Rheumatoid Arthritis.
LD and GC012F CAR-T Cell Injection, GC012F CAR-T Cell Injection - Rheumatoid Arthritis
Early Phase 1WithdrawnInstitute of Hematology & Blood Diseases Hospital, China2027-12-012026-06-10
Patient-Reported Outcomes Dashboard With Goal Setting to Support Shared Decision-Making in Inflammatory Arthritis
Patient-Reported Outcomes Dashboard With Goal Setting - Arthritis, Psoriatic (PsA), Arthritis, Rheumatoid (RA)
Not applicableNot yet recruitingNorthwestern University1602027-01-012026-10-15
Penn SICCA Follow-up Study
Dry Eye, Sjogren's Syndrome
Not yet recruitingUniversity of Pennsylvania2202027-01-012026-03-02
Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis
Nurse-led telehealth remote self-monitoring - Rheumatoid Arthritis (RA)
Not applicableNot yet recruitingCHU de Quebec-Universite Laval1042027-01-012026-10-22
An Open-label Phase I/II Safety and Feasibility Basket Study of UKT-CART19.1
CAR-T cells targeting CD19 - Pemphigus Vulgaris (PV), ANCA Associated Vasculitis (AAV)
Phase 1 / Phase 2Not yet recruitingUniversity Hospital Tuebingen362027-01-012026-11-12
Added Value of HR-pQCT in Detecting Calcium Deposits in Rheumatoid Arthritis
High-Resolution peripheral Quantitative Computed Tomography Imaging - Rheumatoid Arthritis (RA), Calcium Pyrophosphate Deposition Disease
Not applicableNot yet recruitingIstituto Ortopedico Rizzoli1402027-01-012026-11-17
Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers
Deucravacitinib - Systemic Lupus Erythematosus, Sjögren's Disease
Phase 3Not yet recruitingBristol-Myers Squibb23002026-12-312026-09-03
Platform Study of Targeted Therapies for Adults With Moderately to Severely Active Rheumatoid Arthritis
ABBV-722, Upadacitinib - Rheumatoid Arthritis
Phase 2Not yet recruitingAbbVie2502026-12-072026-11-10
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
anti-CD19 CAR-T cells - Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE)
Phase 1Not yet recruitingGustave Roussy, Cancer Campus, Grand Paris62026-12-012026-09-02
Safety and Efficacy of Topical Infliximab in Autoimmune Dry Eye Disease
Infliximab 0.1%, Loteprednol - Sjogren Syndrome, Sjogren Syndrome With Keratoconjunctivitis
Phase 2Not yet recruitingInstituto de Oftalmología Fundación Conde de Valenciana382026-12-012026-06-26
Exosome and Mesenchymal Stem Cell Treatment for Salivary Gland Dysfunction in Primary Sjögren Syndrome
exosomes derived from human umbilical cord mesenchymal stem cells, Mesenchymal Stem Cells (MSC), Placebo - Sjogren Syndrome, Xerostomia
Phase 2Not yet recruitingBanu Erkal302026-12-012026-09-24
Evaluation of Dapagliflozin and Empagliflozin as Adjunctive Therapy to Methotrexate in Patients With Rheumatoid Arthritis
Dapagliflozin, Empagliflozin, Methotrexate - Rheumatoid Arthritis (RA)
Phase 2Not yet recruitingAl-Azhar University902026-12-012026-10-08
Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis
hUC-MSC suspension, Placebo - Rheumatoid Arthritis
Phase 1Not yet recruitingBaylx Inc.162026-12-012025-12-23
The Impact of Rheumatoid Arthritis Treatments on the Modulation of Extracellular Vesicles and Other Biomarkers Involved in the Development of Lung Cancer
Rheumatoid Arthritis (RA), Lung Neoplasms
Not yet recruitingUniversity Hospital, Limoges1362026-12-012026-11-04
MYTP01 for Immune-Mediated Diseases
MYTP01, MYTP01 Placebo - IgA Nephropathy, Kidney Transplant Recipients
Not applicableNot yet recruitingZhejiang Provincial People's Hospital1602026-12-012026-11-04
An Ascending Dose Study of DKB903 in Participants With Rheumatoid Arthritis (RA) and Participants With Systemic Lupus Erythematosus (SLE)
DKB903 - Rheumatoid Arthritis and Systemic Lupus Erythematosus
Phase 1Not yet recruitingNovartis Pharmaceuticals902026-12-012026-11-06
A Phase 1 Study of QLS2416 Injection in Participants With Autoimmune Diseases
QLS2416 Injection - Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA)
Phase 1Not yet recruitingShanghai Qilu Pharmaceutical Research and Development Center LTD762026-12-012026-10-30
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Pericarditis, Tako-TSUBO Cardiomyopathy
Not yet recruitingAssistance Publique - Hôpitaux de Paris3002026-12-012026-11-13
Application of the Personalized N-of-1 Trial Design in Patients With Rheumatoid Arthritis
Etanercept, Adalimumab, Upadacitinib - Arthritis, Rheumatoid
RecruitingTufts Medical Center182026-12-012026-11-16

Showing 20 of 3590. Sign in to see all of them.

Narrower conditions

Sjogren's Syndrome (322)  ·  Osteoarthritis (238)  ·  Arthritis (221)  ·  Arthritis, Psoriatic (184)  ·  Lupus Erythematosus, Systemic (154)  ·  Spondylitis, Ankylosing (128)  ·  Autoimmune Diseases (112)  ·  Osteonecrosis (94)  ·  Scleroderma, Systemic (87)  ·  Inflammation (72)  ·  Crohn Disease (70)  ·  Motor Activity (66)  ·  Joint Diseases (63)  ·  Spondylarthritis (63)

Broader conditions

Skin and Connective Tissue Diseases (3590)  ·  Immune System Diseases (3580)  ·  Musculoskeletal Diseases (3563)  ·  Connective Tissue Diseases (3559)  ·  Rheumatic Diseases (3531)  ·  Joint Diseases (3527)  ·  Autoimmune Diseases (3477)  ·  Arthritis (3369)  ·  Pathological Conditions, Signs and Symptoms (424)  ·  Bone Diseases (407)  ·  Stomatognathic Diseases (360)  ·  Mouth Diseases (355)  ·  Eye Diseases (335)  ·  Skin Diseases (327)  ·  Lacrimal Apparatus Diseases (321)

Interventions

Methotrexate (289)  ·  tocilizumab (165)  ·  Adalimumab (159)  ·  Etanercept (137)  ·  Abatacept (94)  ·  Rituximab (93)  ·  Infliximab (88)  ·  tofacitinib (74)  ·  Certolizumab Pegol (68)  ·  golimumab (41)  ·  Hydroxychloroquine (39)  ·  Folic Acid (34)  ·  baricitinib (34)  ·  Antirheumatic Agents (33)  ·  Leflunomide (32)

Sponsors

Hoffmann-La Roche (186)  ·  Pfizer (124)  ·  Bristol-Myers Squibb (91)  ·  Amgen (62)  ·  Zimmer Biomet (57)  ·  AbbVie (47)  ·  Assiut University (47)  ·  GlaxoSmithKline (42)  ·  AstraZeneca (39)  ·  Eli Lilly and Company (36)  ·  Abbott (33)  ·  AbbVie (prior sponsor, Abbott) (32)  ·  Novartis Pharmaceuticals (31)  ·  Assistance Publique - Hôpitaux de Paris (30)  ·  University Hospital, Montpellier (30)

Countries

United States (1064)  ·  France (403)  ·  Germany (381)  ·  United Kingdom (334)  ·  Poland (305)  ·  China (295)  ·  Spain (285)  ·  Canada (267)  ·  Hungary (221)  ·  Italy (215)  ·  Mexico (210)  ·  Czechia (201)  ·  South Korea (201)  ·  Belgium (197)  ·  Russia (192)

Results publications

PMID 36600185, PMID 36601090, PMID 36931693, PMID 36526796, PMID 32816215, PMID 33127856, PMID 34870800, PMID 28143815, PMID 39192350, PMID 25047021, PMID 27338778, PMID 38958913, PMID 29244149, PMID 30649524, PMID 37453736, PMID 26275429, PMID 33263165, PMID 34706874, PMID 29463520, PMID 34041702, PMID 31610021, PMID 36205910, PMID 37747626, PMID 28941219, PMID 30177460, PMID 35577477, PMID 36715850, PMID 36754548, PMID 36814062, PMID 37308218, PMID 37945286, PMID 37982966, PMID 40875187, PMID 22491018, PMID 27889300, PMID 29949132, PMID 30219772, PMID 30842122, PMID 33057725, PMID 33059710, PMID 33115760, PMID 34921355, PMID 36125701, PMID 37925660, PMID 41448717, PMID 24429164, PMID 24498318, PMID 29246162, PMID 29329602, PMID 30058112

NIH funding

2015 (30), 2009 (29), 2016 (25), 2008 (22), 2025 (19), 2014 (18), 2018 (15), 2017 (12), 2019 (11), 2023 (11), 2005 (10), 2004 (6), P60AR047782 (3), R01AR056702 (2), F31AT003362 (1)